Innovator Liability Theory Will Be Reviewed By California Supreme Court

(June 20, 2016, 9:39 AM EDT) -- SAN FRANCISCO — The California Supreme Court on June 8 granted review in an innovator liability drug case (H. [T.] v. Novartis Pharmaceuticals Corp., No. S233898, Calif. Sup.).

In a docket entry, the high court said it will review the following issue: “May the brand name manufacturer of a pharmaceutical drug that divested all ownership interest in the drug be held liable for injuries caused years later by another manufacturer’s generic version of that drug?”

In March, the Fourth District California Court of Appeal reversed a...
To view the full article, register now.